Trials / Recruiting
RecruitingNCT06880094
Study of Congenital Orofacial Clefts by Implementing Optical Genome Mapping
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 26 (estimated)
- Sponsor
- Centre Hospitalier Universitaire, Amiens · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
Orofacial clefts, the most common congenital craniofacial malformations, have a complex etiology involving an interaction between genetic and environmental factors. Chromosomal abnormalities, including structural variations, represent a major cause of human pathology. Recently, technological developments and the introduction of next-generation sequencing (NGS) technologies have revolutionized the field of medical genetics. Optical genome mapping (OGM) is an innovative, high-resolution "long read" technique that enables the identification of all classes of chromosomal variation, consisting in the direct visualization of long, labeled DNA molecules throughout the genome. This technology is gradually becoming an essential tool for studying onco-hematology and constitutional genetic pathologies The purpose of this study is to search for structural chromosomal variants (SV) or copy number variants (CNV) not identifiable either by cytogenetic methods nor by "short read" NGS "short read, in individuals with oral-facial clefts with no genetic diagnosis.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| GENETIC | blood withdrawal | blood withdrawal for genetic testing |
Timeline
- Start date
- 2025-02-18
- Primary completion
- 2027-04-01
- Completion
- 2027-04-01
- First posted
- 2025-03-17
- Last updated
- 2026-01-16
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06880094. Inclusion in this directory is not an endorsement.